OneSource Specialty Pharma Ltd ONESOURCE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,478.20
- Day Range
- ₹1,438.20–1,491.10
- 52-Week Range
- ₹1,077.40–1,925.00
- Bid/Ask
- ₹1,452.10 / ₹1,461.30
- Shares Outstanding
- 114.67M
- Market Cap
- ₹167.57B
- Volume/Avg
- 194,585 / 284,992
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 11.36
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segment is CDMO (Contract Development and ManufacturingOrganization (CDMO) : Development and manufacture of pharmaceutical products and associated services).
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,289
- Website
- https://www.onesourcecdmo.com
Valuation
|
Metric
|
ONESOURCE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.88 |
Price/Sales | 11.36 |
Price/Cash Flow | 100.82 |
Price/Earnings
ONESOURCE
Financial Strength
|
Metric
|
ONESOURCE
|
|---|---|
Quick Ratio | 0.59 |
Current Ratio | 0.99 |
Interest Coverage | 0.46 |
Quick Ratio
ONESOURCE
Profitability
|
Metric
|
ONESOURCE
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ONESOURCE
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|JC@Q%H< | LOCK|!$Hf | $129B | |||
| Moderna Inc
MRNA
| LOCK|@T&vGd& | LOCK|jy | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|<#PRJ! | LOCK|vhTlY | $77B | |||
| argenx SE ADR
ARGX
| LOCK|Q%L@^^ | LOCK|wY^ | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|m@?VS<! | LOCK|rL# | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|&!Xr>bM | LOCK|RDcxX | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|D>y>?zt | LOCK|Jjpw | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|VqZyBln | LOCK|s#? | $24B | |||
| Incyte Corp
INCY
| LOCK|%PsH@tQ | LOCK|HZ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|%Wg<tc | LOCK|&@b | $14B |
United States